The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical package, a growing maze of regulatory frameworks, and mounting global competition, the industry is grappling with a critical question: Are we at a turning point for Europe’s pharmaceutical...

The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”.  

This high-level briefing from the Financial Times, in partnership with Syneos Health, will bring together leading executives and investors to focus on what it takes to succeed in Europe’s launch environment.

The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for Life Sciences Product Liability, Policy & Dispute Resolution.

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.

Join the EFGCP Conference 2026 in Brussels to explore how ethical review systems can strengthen Europe’s clinical research landscape.

Europe stands at a critical moment for its life sciences sector. Across the world, governments are actively strengthening their biotechnology ecosystems through investment, faster regulatory systems and targeted industrial strategies.

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances in treatment. Late diagnosis, inconsistent screening approaches, variability in care pathways, and gaps in preventive action continue to hinder progress.

At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening, and Europe faces unprecedented geopolitical challenges, we need to rethink healthcare.

Caught between geopolitical turmoil, mounting pressure to deliver growth and war raging at its doorstep, the EU stands at a crossroads: Will it reform, grow and reclaim global influence or stagnate and put its economic power and security on the line?

Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.

Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation to patients.

Join this Euractiv Hybrid Conference to explore how the revised Urban Wastewater Treatment Directive and its EPR scheme can be implemented effectively, fairly, and sustainably, while balancing environmental ambition with industrial competitiveness and public health needs.

Discover how in-kind contributions from industry are key to the success of IHI projects, allowing them to deliver results that would not be possible via other funding models.

Get ready for C5’s 2nd Annual European Summit for Women Leaders in Life Sciences Law — two days of impactful discussions, diverse perspectives, and meaningful connections.

Join the Health Economics and Policy Evaluation ONLINE Course 2026, delivered by the University of Oxford.